China National Biotech Group to IPO on the Hong Kong Exchange

Published: Nov 07, 2011

November 4, 2011 -- China National Biotechnology Group (CNBG) plans a Hong Kong IPO, according to Zhiping Song, Chairman of its parent, China National Pharmaceutical Group Corporation (SinoPharm Group). CNBG, which will change its name to China Biotech, is comprised of six institutes of biological products. So far, no predictions of the size of the offering have been published. More details....

Back to news